Protein Succination: a Mechanistic Mediator of Adipocyte Dysfunction in Diabetes
蛋白质琥珀化:糖尿病脂肪细胞功能障碍的机制介质
基本信息
- 批准号:9117530
- 负责人:
- 金额:$ 13.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAdipocytesAdipose tissueAffectAmericanAntioxidantsAttentionBiochemicalCCAAT-Enhancer-Binding ProteinsChemicalsCitric Acid CycleCysteineDataDepositionDevelopmentDiabetes MellitusEarly treatmentEndocrineEndoplasmic ReticulumEnzymesFeedbackFumarate HydrataseFumaratesFunctional disorderGlucoseHealthHomologous ProteinIn VitroInflammationInner mitochondrial membraneInsulin ResistanceKnock-outKnockout MiceLaboratoriesLeadLinkLipidsLiverMediatingMediator of activation proteinMetabolicMetabolic stressMetabolismMitochondriaMitochondrial DiseasesModelingModificationMuscleNADHNF-E2-related factor 2Non-Insulin-Dependent Diabetes MellitusNutrientOxidation-ReductionOxidative StressPathway interactionsPeripheralPost-Translational Protein ProcessingPrediabetes syndromeProtein Disulfide IsomeraseProteinsPyruvate CarboxylaseReactionRoleSelenocysteineStressSulfhydryl CompoundsTissuesUbiquitinationWorkadiponectinbasedb/db mouseebselenendoplasmic reticulum stressglucose toleranceglutathione peroxidaseinflammatory markerinnovationinsulin toleranceknock-downmouse modelnovelnovel therapeutic interventionnovel therapeuticsoverexpressionpreventprotein foldingprotein misfoldingprotein structure functionresponseselenoproteinsmall hairpin RNAtargeted treatmentthioredoxin reductase
项目摘要
DESCRIPTION (provided by applicant): Considering that ~26 million Americans have diabetes and an estimated 79 million have prediabetes, it is critical that we understand the role of expanding adipose tissue mass in the development of systemic metabolic dysfunction. However, many of the biochemical mechanisms underlying adipose tissue dysfunction remain unclear. Previously, we have detected S-(2-succinol)cysteine (2SC), also termed protein succination, a new chemical post-translational modification of proteins. 2SC is formed by reaction of the Krebs cycle intermediate fumarate with reactive cysteine residues in protein. Both fumarate and succination of proteins appear to be selectively increased in adipocytes in diabetes, impairing protein structure and function. The increase in fumarate develops as a result of excess fuel supply, accumulation of ATP and NADH, inner mitochondrial membrane (IMM) hyperpolarization and consequently feedback inhibition of the Krebs cycle. This proposal hypothesizes that the increase in protein succination is a novel mechanistic link between mitochondrial stress and the accumulation of misfolded proteins, contributing to endoplasmic reticulum (ER) stress in the adipocyte in diabetes. In addition, we propose that the succination of redox-active proteins modulates redox stress in diabetes. This project has 3 specific aims: (1) To examine the impact of fumarate accumulation and selective succination in the adipocyte; (2) To determine if succination mechanistically links mitochondrial and ER stress in the adipocyte; and (3) To examine the reactivity of fumarate with protein selenocysteines as a novel redox modulator. We plan to use a novel knockout mouse with selective fumarate accumulation in the adipose tissue. Upon completion of these studies, we will demonstrate the significant contribution of adipocyte protein succination to metabolic dysfunction in diabetes, with important implications for the development of novel therapeutic avenues for the treatment of mitochondrial diseases.
描述(由适用提供):考虑到约有2600万美国人患有糖尿病,估计有7900万具有糖尿病前期,至关重要的是,我们了解扩大脂肪组织质量在系统性代谢功能障碍发展中的作用。但是,尚不清楚脂肪组织功能障碍的许多生化机制尚不清楚。以前,我们已经检测到S-(2-核醇)半胱氨酸(2SC),也称为蛋白质琥珀酸酯,这是一种新的化学化学后翻译后蛋白质修饰。 2SC是通过富马酸群中间体与反应性半胱氨酸在蛋白质中的反应形成的。在糖尿病的脂肪细胞中,蛋白质的富马酸酯和蛋白质的锻炼似乎有选择性地增加,损害了蛋白质的结构和功能。由于燃料供应过多,ATP和NADH的积累,内部线粒体膜(IMM)超极化以及KREBS循环的反馈抑制。该提议假设蛋白质琥珀酸的增加是线粒体应激与错误折叠蛋白的积累之间的新机械联系,导致糖尿病脂肪细胞中内质网应激(ER)胁迫。此外,我们建议氧化还原活性蛋白的琥珀色调节糖尿病中的氧化还原应激。该项目具有3个特定的目的:(1)检查脂肪细胞中富马酸盐积累和选择性琥珀的影响; (2)确定琥珀酸是否会在脂肪细胞中将线粒体和ER应力联系起来; (3)检验富马酸酯与蛋白质硒代蛋白作为一种新型氧化还原调节剂的反应性。我们计划在脂肪组织中使用具有选择性富马酸酯积累的新型基因敲除小鼠。这些研究完成后,我们将证明脂肪细胞蛋白辅助对糖尿病中代谢功能障碍的显着贡献,这对新型治疗途径的发展对治疗线粒体疾病的治疗具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Norma Frizzell其他文献
Norma Frizzell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Norma Frizzell', 18)}}的其他基金
Developing Tools to Understand an Alternative Fate of Urate in Neurodegenerative Diseases
开发工具来了解尿酸盐在神经退行性疾病中的替代命运
- 批准号:
10668103 - 财政年份:2023
- 资助金额:
$ 13.35万 - 项目类别:
Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial Encephalopathy
研究复合物 I 缺陷型线粒体脑病中柠檬酸循环的扰动
- 批准号:
10609528 - 财政年份:2022
- 资助金额:
$ 13.35万 - 项目类别:
Anaplerotic Therapy for Mitochondrial Complex I Deficiency
线粒体复合物 I 缺乏症的回补疗法
- 批准号:
10118501 - 财政年份:2020
- 资助金额:
$ 13.35万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
8942973 - 财政年份:2015
- 资助金额:
$ 13.35万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
9268095 - 财政年份:2015
- 资助金额:
$ 13.35万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
9122509 - 财政年份:2015
- 资助金额:
$ 13.35万 - 项目类别:
Detection of S-(2-succino)cysteine (2SC) as a Biomarker of Mitochondrial Disease
检测 S-(2-琥珀酰)半胱氨酸 (2SC) 作为线粒体疾病的生物标志物
- 批准号:
8571892 - 财政年份:2013
- 资助金额:
$ 13.35万 - 项目类别:
Detection of S-(2-succino)cysteine (2SC) as a Biomarker of Mitochondrial Disease
检测 S-(2-琥珀酰)半胱氨酸 (2SC) 作为线粒体疾病的生物标志物
- 批准号:
8725715 - 财政年份:2013
- 资助金额:
$ 13.35万 - 项目类别:
相似国自然基金
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Arid5b调控Treg细胞脂肪组织适应性发育和代谢调控功能及机制探究
- 批准号:82371752
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
巨噬细胞Lp-PLA2对脂肪组织重塑的调控及其作用机制
- 批准号:32300977
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞介导脂肪组织重构在塑化剂干扰系统能量代谢中的作用研究
- 批准号:82373625
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Development of Modified Caveolin-1 Scaffolding Domain Peptides with Improved Pharmacological Properties as Therapeutic Agents for Scleroderma Skin Disease
开发具有改善药理特性的修饰的 Caveolin-1 支架结构域肽作为硬皮病皮肤病的治疗剂
- 批准号:
10544238 - 财政年份:2022
- 资助金额:
$ 13.35万 - 项目类别:
Selenium metabolism in cold-induced adaptive thermogenesis
冷诱导适应性产热中的硒代谢
- 批准号:
10186406 - 财政年份:2021
- 资助金额:
$ 13.35万 - 项目类别:
Selenium metabolism in cold-induced adaptive thermogenesis
冷诱导适应性产热中的硒代谢
- 批准号:
10713400 - 财政年份:2021
- 资助金额:
$ 13.35万 - 项目类别:
Selenium metabolism in cold-induced adaptive thermogenesis
冷诱导适应性产热中的硒代谢
- 批准号:
10579270 - 财政年份:2021
- 资助金额:
$ 13.35万 - 项目类别:
Selenium metabolism in cold-induced adaptive thermogenesis
冷诱导适应性产热中的硒代谢
- 批准号:
10396667 - 财政年份:2021
- 资助金额:
$ 13.35万 - 项目类别: